SE7508101L - Sett att framstella nya kinazolinderivat med terapeutisk verkan. - Google Patents

Sett att framstella nya kinazolinderivat med terapeutisk verkan.

Info

Publication number
SE7508101L
SE7508101L SE7508101A SE7508101A SE7508101L SE 7508101 L SE7508101 L SE 7508101L SE 7508101 A SE7508101 A SE 7508101A SE 7508101 A SE7508101 A SE 7508101A SE 7508101 L SE7508101 L SE 7508101L
Authority
SE
Sweden
Prior art keywords
way
therapeutic effect
produce new
chinazoline derivatives
chinazoline
Prior art date
Application number
SE7508101A
Other languages
English (en)
Other versions
SE420921B (sv
Inventor
J C Danilewics
A G Evans
A L Ham
C Thomson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7508101L publication Critical patent/SE7508101L/sv
Publication of SE420921B publication Critical patent/SE420921B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7508101A 1974-07-25 1975-07-15 Analogiforfarande for framstellning av kinazolinderivat med terapeutisk verkan SE420921B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3280574 1974-07-25
GB41675*[A GB1460389A (en) 1974-07-25 1975-01-06 4-substituted quinazoline cardiac stimulants

Publications (2)

Publication Number Publication Date
SE7508101L true SE7508101L (sv) 1976-01-26
SE420921B SE420921B (sv) 1981-11-09

Family

ID=26235904

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7508101A SE420921B (sv) 1974-07-25 1975-07-15 Analogiforfarande for framstellning av kinazolinderivat med terapeutisk verkan

Country Status (23)

Country Link
US (1) US4001422A (sv)
JP (1) JPS5527062B2 (sv)
AR (7) AR216046A1 (sv)
BG (2) BG27744A3 (sv)
CA (1) CA1060445A (sv)
CH (2) CH611616A5 (sv)
DD (1) DD119046A5 (sv)
DE (1) DE2530894C2 (sv)
DK (1) DK138800B (sv)
FI (1) FI66182C (sv)
FR (1) FR2279406A1 (sv)
GB (1) GB1460389A (sv)
HK (1) HK61879A (sv)
IE (1) IE41838B1 (sv)
IL (1) IL47625A (sv)
KE (1) KE2988A (sv)
LU (1) LU73072A1 (sv)
MY (1) MY8000108A (sv)
NL (1) NL159982C (sv)
PH (1) PH14190A (sv)
RO (3) RO71840A (sv)
SE (1) SE420921B (sv)
YU (3) YU37155B (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148482B (sv) 1977-06-03 1981-03-07 Pfizer
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
CA1086735A (en) * 1977-11-03 1980-09-30 John C. Danilewicz Piperidino-quinazolines
US4489075A (en) * 1982-05-15 1984-12-18 Pfizer Inc. Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
US6645969B1 (en) * 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
FR2802206B1 (fr) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
TWI283665B (en) * 2001-09-13 2007-07-11 Smithkline Beecham Plc Novel urea compound, pharmaceutical composition containing the same and its use
HUP0200849A2 (hu) * 2002-03-06 2004-08-30 Sanofi-Synthelabo N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
US7064211B2 (en) * 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
WO2004024710A1 (en) * 2002-09-13 2004-03-25 Glaxo Group Limited Urea compounds active as vanilloid receptor antagonists for the treatment of pain
TWI350168B (en) 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
BRPI0512410A (pt) * 2004-06-24 2008-03-04 Incyte Corp compostos de amido e seu uso como produtos farmacêuticos
CA2589565A1 (en) * 2004-06-24 2006-01-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
CA2570637A1 (en) 2004-06-24 2006-02-02 Wenqing Yao N-substituted piperidines and their use as pharmaceuticals
WO2006002361A2 (en) * 2004-06-24 2006-01-05 Incyte Corporation 2-methylpropanamides and their use as pharmaceuticals
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
EP1778229A4 (en) * 2004-08-10 2009-06-17 Incyte Corp AMID COMPOUNDS AND THEIR USE AS MEDICAMENTS
US7825244B2 (en) * 2005-06-10 2010-11-02 Janssen Pharmaceutica Nv Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
US8071768B2 (en) * 2005-06-10 2011-12-06 Janssen Pharmaceutica, N.V. Alkylquinoline and alkylquinazoline kinase modulators
TW200808807A (en) * 2006-03-02 2008-02-16 Incyte Corp Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
WO2007103719A2 (en) * 2006-03-03 2007-09-13 Incyte Corporation MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
US20070293529A1 (en) * 2006-05-01 2007-12-20 Yun-Long Li Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
WO2007137066A2 (en) * 2006-05-17 2007-11-29 Incyte Corporation HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
EP1903038A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
MA54879A (fr) * 2019-02-01 2021-12-08 Univ Leland Stanford Junior Inhibiteurs d'enpp1 et méthodes de modulation de réponse immunitaire
US11407729B2 (en) 2019-03-19 2022-08-09 Stingray Therapeutics, Inc. Quinoline and quinazoline compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3637701A (en) * 1969-03-03 1972-01-25 Sandoz Ag Certain nitrate derivatives of 4-aminoquinazolines
DE2121031A1 (en) * 1971-04-29 1972-11-02 Dr. Karl Thomae Gmbh, 7950 Biberach Base-substd quinazolines - thrombocyte aggregation inhibitors
BE793371A (fr) * 1971-12-27 1973-06-27 Sandoz Sa Nouveaux derives de la 4-amino-quinazoline, leur preparation etmedicaments contenant ces
US3819628A (en) * 1972-07-31 1974-06-25 Sandoz Ag 2-phenyl-4-substituted amino-quinazolines and nitrates thereof
US3838127A (en) * 1972-10-19 1974-09-24 Sandoz Ag 4-(4-(hydroxyalkyl)-1-piperazino)-quinazoline benzoates
GB1417029A (en) * 1973-03-07 1975-12-10 Pfizer Ltd Quinazoline-derived amines

Also Published As

Publication number Publication date
YU37155B (en) 1984-08-31
HK61879A (en) 1979-09-07
RO69296A (ro) 1981-08-30
YU184275A (en) 1983-04-27
IE41838L (en) 1976-01-25
YU124281A (en) 1983-04-30
NL159982B (nl) 1979-04-17
DK138800C (sv) 1979-04-09
US4001422A (en) 1977-01-04
CH608803A5 (sv) 1979-01-31
FI66182B (fi) 1984-05-31
AR212447A1 (es) 1978-07-14
SE420921B (sv) 1981-11-09
AR214050A1 (es) 1979-04-30
IL47625A0 (en) 1975-10-15
RO71840A (ro) 1982-09-09
AR214049A1 (es) 1979-04-30
JPS5136469A (sv) 1976-03-27
MY8000108A (en) 1980-12-31
BG27086A3 (sv) 1979-08-15
DE2530894A1 (de) 1976-02-05
GB1460389A (en) 1977-01-06
FI752104A (sv) 1976-01-26
LU73072A1 (sv) 1977-03-24
KE2988A (en) 1979-09-28
FI66182C (fi) 1984-09-10
DK138800B (da) 1978-10-30
CH611616A5 (sv) 1979-06-15
AU8317475A (en) 1977-01-20
DD119046A5 (sv) 1976-04-05
DE2530894C2 (de) 1983-12-22
PH14190A (en) 1981-03-26
YU124181A (en) 1983-04-30
NL159982C (nl) 1979-09-17
DK337175A (sv) 1976-01-26
JPS5527062B2 (sv) 1980-07-17
AR213407A1 (es) 1979-01-31
AR215882A1 (es) 1979-11-15
AR207895A1 (es) 1976-11-08
IE41838B1 (en) 1980-04-09
RO71841A (ro) 1980-08-15
IL47625A (en) 1981-01-30
NL7508824A (nl) 1976-01-27
BG27744A3 (en) 1979-12-12
AR216046A1 (es) 1979-11-30
FR2279406B1 (sv) 1980-04-30
CA1060445A (en) 1979-08-14
FR2279406A1 (fr) 1976-02-20

Similar Documents

Publication Publication Date Title
SE7508101L (sv) Sett att framstella nya kinazolinderivat med terapeutisk verkan.
SE420718B (sv) Sett att framstella nya dekapeptidamidderivat med ovalationsinducerande aktivitet
SE7614680L (sv) Sett att framstella nya bensodiazepinderivat
SE397520B (sv) Sett att framstella nya nonapeptidamidderivat med ovulationsinducerande aktivitet
SE417204B (sv) Sett att framstella nya kinoxalin- och kinazolinderivat
SE405115B (sv) Sett att framstella nya fenyl-imidazolyl-alkanylderivat med antimykotisk verkan
SE393383B (sv) Sett att framstella adenosinderivat
SE7711848L (sv) Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat
SE411349B (sv) Sett att framstella nya penicilliner
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE408300B (sv) Sett att framstella nya dipeptidderivat
SE427108B (sv) Sett att framstella nya substituerade fenylettiksyror med inflammationshemmande verkan
SE7602729L (sv) Sett att framstella nya indolylalkylpiperidiner
SE382215B (sv) Sett att framstella kromanderivat
SE7511328L (sv) Sett att framstella nya pyridinderivat
SE7609426L (sv) Sett att framstella nya oxazolidinoner
SE415971B (sv) Sett att framstella substituerade bensamider med terapeutisk verkan
SE386164B (sv) Sett att framstella nya 2-alkylamino-dihydropyridiner
SE7606178L (sv) Sett att framstella nya cefalosporinderivat
SE7509513L (sv) Sett att framstella bietamidderivat
SE397679B (sv) Sett att framstella kinazolinonderivat
SE7509209L (sv) Sett att framstella nya kinolinderivat
SE415252B (sv) Sett att framstella nya oxifenylbutazonderivat
SE7609666L (sv) Sett att framstella nya 5-aminometyltiazolderivat
SE412233B (sv) Sett att framstella nya fenotiazinderivat